## VLTO: Veralto Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.9% below STRENGTH zone (3.0-6.0%); PEG 3.35 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($95.14)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Veralto Corp. stock falls Wednesday, underperforms market**
- Source: MarketWatch | 20251231T170200 | Bearish | Relevance: 100%
- Veralto Corp. stock (VLTO) declined by 1.43% to $99.78 on Wednesday, underperforming the broader market. This marked the stock's fifth consecutive day of losses, as the S&P 500 Index and Dow Jones Industrial Average also experienced declines.

**2. Cwm LLC Acquires 41,849 Shares of Veralto Corporation $VLTO**
- Source: MarketBeat | 20251231T094826 | Somewhat-Bullish | Relevance: 100%
- Cwm LLC significantly increased its stake in Veralto Corporation (NYSE:VLTO) by 187.1% during the third quarter, acquiring an additional 41,849 shares and bringing its total holdings to 64,211 shares valued at $6,846,000. Other institutional investors also adjusted their positions, with notable new purchases from Norges Bank and substantial increases by Alliancebernstein L.P. and DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main. Veralto recently beat earnings estimates, increased its quarterly dividend, and received varied analyst ratings, indicating continued investor and analyst interest.

**3. Pacer Advisors Inc. Sells 15,402 Shares of Veralto Corporation $VLTO**
- Source: MarketBeat | 20260101T110859 | Somewhat-Bullish | Relevance: 100%
- Pacer Advisors Inc. reduced its stake in Veralto Corporation (NYSE:VLTO) by 43.4%, selling 15,402 shares and retaining 20,102 shares valued at $2.14 million. This reduction occurred as institutional investors collectively own approximately 91.28% of the company's stock. Veralto also recently exceeded Q3 EPS expectations, announced FY2025 guidance, and increased its quarterly dividend.

**4. Danaher stock in focus: defensive quality meets cautious optimism as Wall Street updates its targets**
- Source: AD HOC NEWS | 20260101T100829 | Somewhat-Bullish | Relevance: 61%
- Danaher's stock has shown solid gains over the past year despite a life-sciences downcycle and spin-off, attracting renewed interest from Wall Street analysts. The company's resilient margins, coupled with signs of stabilizing bioprocessing demand and strategic portfolio optimization, are contributing to a cautious yet optimistic outlook among investors. Analysts generally maintain positive ratings, anticipating further upside as the company navigates market recovery and continues its disciplined growth strategy.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Jefferies | $105 | $125 | -16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Jefferies | down | Hold |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.8%)
- Blackrock Inc.: 9.7% (+0.2%)
- State Street Corpora: 4.2% (+1.9%)
- Geode Capital Manage: 2.9% (+4.6%)
- T. Rowe Price Invest: 2.8% (-14.1%)

### Key Risks

1. Valuation stretched: PEG 3.4x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.35 signals overvaluation risk, limited margin of safety. Forward P/E 23.6x stretched relative to 9% growth. Quality metrics strong (ROE 38%, ROA 12%, margin 17%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $24.5B |
| Beta | 1.11 |
| 52W Range | $83.86 - $110.11 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.35 |
| Forward P/E | 23.6 |
| Current P/E | 25.6 |
| YoY Growth | 8.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.5% to -1.9% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.8pp (needs >3.0% for momentum thesis). Underperforming sector by 3.9pp, stock-specific weakness. Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 41. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.85% (CS: 13) | Neutral |
| RSI_14 | 40.8 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 0.981x | Below |
| vs SMA50 | 0.982x | Below |
| vs SMA200 | 0.976x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $98.50
- **Stop Loss:** $95.14 (3.4% risk)
- **Target:** $101.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 428
- **Position Value:** $42,158.00
- **Portfolio %:** 42.16%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-03 (Est: $0.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.95 | $0.99 | +4.4% |
| 2025Q2 | $0.88 | $0.93 | +5.2% |
| 2025Q1 | $0.87 | $0.95 | +9.6% |
| 2024Q4 | $0.89 | $0.95 | +6.5% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*